Savara (SVRA) Other Operating Expenses (2010 - 2026)
Savara (SVRA) posted quarterly Other Operating Expenses of $24000.0 for Q1 2026, down 20.0% year-over-year from $30000.0 in Q1 2025, and up 318.18% quarter-over-quarter from -$11000.0 in Q4 2025.
Savara (SVRA) Other Operating Expenses (2010 - 2026) Analysis & Trends
Savara (SVRA) has reported Other Operating Expenses for 17 consecutive years, with $24000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses fell 20.0% year-over-year to $24000.0; the TTM figure through Mar 2026 stood at $83000.0 (down 35.16% YoY), while the FY2025 annual figure was $87000.0, down 33.08% from the prior year.
- Other Operating Expenses grew to $24000.0 in Q1 2026 per SVRA's latest filing, from -$11000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $36000.0 in Q3 2025 and bottomed at -$11000.0 in Q4 2025.
- Historically, Other Operating Expenses has averaged $20705.9 across 5 years, with a median of $30000.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Operating Expenses jumped 357.14% — and 2025, when it tumbled 134.38%.
- Savara's Other Operating Expenses stood at $7000.0 in 2022, then soared by 357.14% to $32000.0 in 2023, then changed by 0.0% to $32000.0 in 2024, then sank by 134.38% to -$11000.0 in 2025, then surged by 318.18% to $24000.0 in 2026.
- Business Quant data shows SVRA's Other Operating Expenses at $24000.0 in Q1 2026, -$11000.0 in Q4 2025, and $36000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Savara | 1.11 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28,000.00 |
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 40,000.00 |